Table 1 Demographic and clinical characteristics of nAMD patients and controls (Mean ± SD)

Age (y)

69.90 ± 7.71

70.17 ± 5.58

69.77 ± 8.63

0.815^a

Female, n (%)

31 (43.1%)

14 (58.3%)

17 (35.4%)

0.064^b

BCVA (LogMar)

0.75 ± 0.49

0.63 ± 0.57

0.81 ± 0.44

0.139^a

Intraocular pressure (mmHg)

13.74 ± 2.34

13.46 ± 2.24

13.88 ± 2.41

0.481^a

Body Mass Index (kg/m²)

23.90 ± 3.03

24.13 ± 2.48

23.79 ± 3.29

0.665^a

History of hypertension, n (%)

33 (45.8%)

10 (41.7%)

23 (47.9%)

0.616^b

History of cardiovascular disease, n (%)

10 (13.9%)

2 (8.3%)

8 (16.7%)

0.547^b

History of cerebrovascular disease, n (%)

6 (8.3%)

1 (4.2%)

5 (10.4%)

0.651^b